Immunohistochemical analysis of Ki67 expression and caspase 3 cleavage activation revealed that blocking Gβγ signaling by Gαt expression or gallein treatment significantly reduced prostate cancer cell proliferation and increased apoptosis in the xenograft tumors (Figure 7A, 7B). Here, CASP3 is linked to prostate carcinoma.